Mr. Speaker, I think debate is always important. Accurate information is as well. I have indicated my concerns about this bill, but it is important to have all the information about it and important that it be debated openly, as I said, with information from independent researchers as well, not necessarily information or advice from large pharmaceutical companies.
I would like to hear from the Canadian Health Coalition and from drug regulatory experts such as Barbara Mintzes and Alan Cassels, whom I cited earlier. Many of these other experts could come before the standing committee. We could hear from them about what the bill would actually do.
I have heard from literally hundreds of constituents, but many of them seem to be fairly well informed about the bill. Some of the information, I have to say, comes from medical doctors who practice holistic medicine and are interested in achieving and ensuring a proper balance between so-called prescription drugs and so-called natural health products, which is not the case at the moment under what is being proposed here.